Showing all 16 results
Erlotinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic API.
Active Ingredient Strength Primary Clinical Function Erlotinib (as Hydrochloride) USP/Ph.Eur. 100 mg The Pancreatic Oncology Standard: The definitive daily maintenance dose utilized globally in combination with Gemcitabine for advanced, unresectable, or metastatic pancreatic cancer. Erlotinib (as Hydrochloride) USP/Ph.Eur. 150 mg The Thoracic Oncology Standard: Massive therapeutic payload utilized as a first-line, maintenance, or second-line daily monotherapy for EGFR-mutated Non-Small Cell Lung Cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize dissolution of this highly insoluble compound while locking the potent cytotoxic API safely inside the tablet, completely preventing handler exposure to carcinogenic dust) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Flutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antiandrogen API.
Active Ingredient Strength Primary Clinical Function Flutamide USP/Ph.Eur. 250 mg Global Uro-Oncology Standard: The definitive therapeutic unit utilized for chronic, 8-hourly maintenance in Maximum Androgen Blockade (MAB) protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the potent antiandrogen API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous hormonal dust) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic oncology dispensing regimens).
Gefitinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Gefitinib USP/Ph.Eur. 250 mg Global Adult Oncology Standard: The definitive, highly precise daily maintenance dose required to maintain constant, paralyzing pressure on the mutated EGFR protein to keep the lung cancer in deep molecular remission. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize the dissolution of this poorly soluble compound while locking the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Hydroxyurea Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Scored Film-Coated Tablet, packed exclusively in highly secure, handler-protective Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure absolute chemical stability and prevent accidental cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Hydroxyurea USP/Ph.Eur. 200 mg / 300 mg / 400 mg Pediatric Sickle Cell Standard: Specialized weight-based units designed for exact mg/kg titration in infants and children suffering from severe vaso-occlusive crises. Hydroxyurea USP/Ph.Eur. 500 mg (Scored) Global Adult Hematology Standard: High-efficacy adult maintenance dose for CML, Polycythemia Vera, and adult Sickle Cell Disease. Excipients Microcrystalline Cellulose / Sodium Citrate / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / pH Stabilizer / Superdisintegrant / Slipper-Coating (Engineered specifically with a heavy, durable film-coat to completely seal the highly toxic, mutagenic core away from nurses, parents, and pharmacists) *Pack Sizes: Bottles of 100 or 10×10 Alu-Alu Blisters (Optimized specifically for massive-volume NGO procurement and chronic lifetime dispensing).
Imatinib Mesylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the mesylate salt.
Active Ingredient Strength Primary Clinical Function Imatinib (as Mesylate) USP/Ph.Eur. 100 mg Pediatric & Titration Standard: Base therapeutic unit utilized for weight-based pediatric leukemia dosing, or for highly precise adult dose adjustments during acute hematological toxicity. Imatinib (as Mesylate) USP/Ph.Eur. 400 mg Global Adult Oncology Standard: High-efficacy adult maintenance dose, typically taken once daily for the chronic phase of CML, or twice daily for accelerated phases and GIST. Excipients Microcrystalline Cellulose / Crospovidone / Hypromellose / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Iron-Oxide Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically to lock the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Letrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micro-dosed endocrine disruptor.
Active Ingredient Strength Primary Clinical Function Letrozole USP/Ph.Eur. 2.5 mg Global Oncology & Fertility Standard: The universal therapeutic unit utilized for 5-to-10 year daily adjuvant breast cancer therapy, or short 5-day cyclic dosing for ovulation induction. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically using elite geometric dilution to ensure the microscopic 2.5mg active payload is flawlessly distributed throughout the tablet, guaranteeing absolute content uniformity) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, heavily monitored chronic oncology dispensing or monthly fertility cycles).
Melphalan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, handler-protective Amber Glass Bottles or specialized Alu-Alu cold-chain blisters to ensure the absolute chemical survival of the highly unstable alkylating agent.
Active Ingredient Strength Primary Clinical Function Melphalan USP/Ph.Eur. 2 mg Global Oncology Standard: Base therapeutic unit allowing for highly precise, weight-based or Body Surface Area (BSA) calculated “pulsed” dosing regimens. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically with a heavy film-coat to ensure immediate gastric transit and to completely seal the highly toxic, mutagenic core away from nurses and caregivers) *Pack Sizes: Amber Glass Bottles of 25/50 Tablets (Optimized specifically for strict, highly monitored hematology dispensing regimens).
Mercaptopurine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, handler-protective Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antimetabolite and protect healthcare workers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Mercaptopurine (as Monohydrate) USP/Ph.Eur. 50 mg Global Oncology & Autoimmune Standard: Scored tablets allowing for highly precise, weight-based or Body Surface Area (BSA) based dose titrations in pediatric and adult populations. Excipients Lactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate / Stearic Acid Diluent / Binder / Disintegrant / Lubricant (Engineered specifically using high-containment wet granulation to prevent airborne cytotoxic dust generation during manufacturing, ensuring precise, even API distribution) *Pack Sizes: Bottles of 25/50 or 10×10 Blisters (Optimized specifically for strict, heavily monitored chronic oncology dispensing regimens).
Oxaliplatin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Aqueous Concentrate in glass vials. (Also available as Lyophilized Powder depending on market preference).
Active Ingredient Strength Volume Oxaliplatin USP/BP 5 mg / ml 10 ml Vial (Total 50 mg) Oxaliplatin USP/BP 5 mg / ml 20 ml Vial (Total 100 mg) Excipients Water for Injection Preservative-Free Solution *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).
Pemetrexed Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Light-Yellow Cake) in glass vials.
Active Ingredient Strength Reconstitution Pemetrexed Disodium 100 mg Requires 0.9% Sodium Chloride Pemetrexed Disodium 500 mg Requires 0.9% Sodium Chloride Pemetrexed Disodium 1000 mg (1 g) High-Dose Protocols Excipients Mannitol / Hydrochloric Acid / Sodium Hydroxide Bulking Agent / pH Adjusters (pH 6.6 – 7.8) *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).
Sorafenib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, child-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the tosylate salt formulation.
Active Ingredient Strength Primary Clinical Function Sorafenib Tosylate INN/Ph.Eur. 200 mg (Equivalent to Sorafenib free base) Global Standard: Base titration unit for the standard 800 mg daily oncology regimen. Excipients Croscarmellose Sodium / Microcrystalline Cellulose / Hypromellose / Magnesium Stearate Superdisintegrant / Diluent / Film-Coating (Engineered for strict gastric dissolution and reliable systemic bioavailability) Tamoxifen Citrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg (Equivalent to Tamoxifen Base) Standard divided-dose therapy and specific prophylactic risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg (Equivalent to Tamoxifen Base) Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Tamoxifen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg Standard divided-dose therapy and specific risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Temozolamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed in highly secure, child-resistant and moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles. We offer the complete range of strengths required for exact, weight-based (Body Surface Area) oncology dosing.
Active Ingredient Strength Primary Clinical Use Temozolomide INN/Ph.Eur. 20 mg Micro-dosing for strict Body Surface Area (BSA) rounding and pediatric protocols. Temozolomide INN/Ph.Eur. 100 mg / 140 mg Standard titration strengths for concurrent radiotherapy and maintenance phases. Temozolomide INN/Ph.Eur. 250 mg High-dose foundation for the 5-day maintenance cycle in adult GBM patients. Excipients Lactose Anhydrous / Colloidal Silicon Dioxide / Sodium Starch Glycolate / Stearic Acid Diluent / Glidant / Superdisintegrant (Engineered for immediate gastric capsule dissolution) Thioguanine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Scored Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles, engineered to maintain absolute stability and physical containment of the cytotoxic agent.
Active Ingredient Strength Primary Clinical Use Thioguanine USP/Ph.Eur. 40 mg Standard Adult/Pediatric Dose (Titrated by Body Surface Area or Weight) for AML and ALL. Excipients Lactose Monohydrate / Potato Starch / Magnesium Stearate / Stearic Acid Diluent / Glidant (Engineered for immediate gastric dispersion and precise tablet splitting)
